Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0111558001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Pre Market | 02365243 | ACCEL PHARMA INC | ACCEL-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Marketed | 02177889 | APOTEX INC | APO-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Dormant | 02230366 | BAUSCH HEALTH, CANADA INC. | CLONAPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Approved | 02173344 | APOTEX INC | CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Cancelled Post Market | 02442035 | SIVEM PHARMACEUTICALS ULC | CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Cancelled Post Market | 02220598 | PRO DOC LIMITEE | CLONAZEPAM-0.5 - TAB 0.5MG | Human | No | Targeted (CDSA IV) | 1 | CLONAZEPAM | .5 MG |
Cancelled Post Market | 02344629 | MELIAPHARM INC | CLONAZEPAM-R | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Cancelled Post Market | 02270641 | COBALT PHARMACEUTICALS COMPANY | CO CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Cancelled Post Market | 02130998 | DOMINION PHARMACAL | DOM-CLONAZEPAM - TAB 0.5MG | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Cancelled Post Market | 02224100 | DOMINION PHARMACAL | DOM-CLONAZEPAM-R - TAB 0.5MG | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Cancelled Post Market | 02230950 | MYLAN PHARMACEUTICALS ULC | MYLAN-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Cancelled Post Market | 02145227 | PHARMEL INC | PHL-CLONAZEPAM - TAB 0.5MG | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | .5 MG |
Cancelled Post Market | 02236948 | PHARMEL INC | PHL-CLONAZEPAM-R | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Marketed | 02048701 | PHARMASCIENCE INC | PMS-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Marketed | 02207818 | PHARMASCIENCE INC | PMS-CLONAZEPAM-R | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Marketed | 02311593 | PRO DOC LIMITEE | PRO-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Cancelled Post Market | 02103656 | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | RATIO-CLONAZEPAM | Human | No | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Marketed | 02242077 | LABORATOIRE RIVA INC. | RIVA-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Marketed | 00382825 | CHEPLAPHARM ARZNEIMITTEL GMBH | RIVOTRIL | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Cancelled Post Market | 02233960 | SANDOZ CANADA INCORPORATED | SANDOZ CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Cancelled Post Market | 02239024 | TEVA CANADA LIMITED | TEVA-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Cancelled Post Market | 02303310 | ZYMCAN PHARMACEUTICALS INC | ZYM-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Cancelled Post Market | 02345676 | ZYMCAN PHARMACEUTICALS INC | ZYM-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 0.5 MG |
Application information
Related information
Contact us
Version 4.0.3